Study for Novel Coronavirus Pneumonia (NCP)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

2000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-02-21

Study Completion Date

2020-07-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To develop practical and effective clinical diagnosis and treatment schemes for the control of novel coronavirus pneumonia.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Clinical Progressive Characteristics and Treatment Effects of 2019-novel Coronavirus

NCT04292327

Pneumonia Caused by Human Coronavirus

UNKNOWN

A New Screening Strategy for 2019 Novel Coronavirus Infection

NCT04281693

Novel Coronavirus Infection Pneumonia

UNKNOWN NA

Clinical Characteristics and Microbiology of Community-Acquired Pneumonia

NCT03098914

Community-acquired Pneumonia

UNKNOWN

Evaluation of Clinical Characteristics and Outcome of COVID19 Pneumonia in Assiut University Hospital

NCT04481360

Coronavirus

UNKNOWN

Use of a Respiratory Multiplex PCR and Procalcitonin to Reduce Antibiotics Exposure in Patients With Severe Confirmed COVID-19 Pneumonia

NCT04334850

Covid19 Pneumonia

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

By retrospectively analyzing the clinical epidemiological characteristics of the novel coronavirus pneumonia and the current diagnosis and treatment schemes, as well as in-depth analyzing the disease development process and outcome trends of NCP patients to develop practical and effective clinical diagnosis and treatment schemes and provide guarantee for the rapid control of the epidemic.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Novel Coronavirus Pneumonia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

systemic treatment

Oxygen therapy, antiviral therapy, antibiotics, hormones, globulin

Intervention Type COMBINATION_PRODUCT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients confirmed with novel coronavirus pneumonia. The Diagnostic criteria refer to "Pneumonitis Diagnosis and Treatment Scheme for Novel Coronavirus Infection (Trial Version 5)";